E-mails indicate drugmakers paid to attend painkiller meetings

Major drugmakers paid as much as $25,000 to attend meetings of a scientific panel that advises the FDA on the effectiveness and safety of painkillers, according to hundreds of e-mails acquired via a public records request. "These e-mails help explain the disastrous decisions the FDA's analgesic division has made over the last 10 years," said lawyer Craig Mayton, who filed the request with the University of Washington. The agency said it was not aware of any impropriety involving group, a private partnership organized by two medical professors.

View Full Article in:

Washington Post (tiered subscription model), The